Asia-Pacific Clinical Chemistry Instruments/Analyzer - Analysis and Forecast to 2019
- Report Code: CL 1001
- Publish Date: Upcoming
Clinical chemistry is the application of chemical, molecular, and cellular concepts and techniques to understand and evaluate the human health. Routine tests including testing for blood albumin, ALT/SGPT, ammonia, blood gases, and calcium and creatinine levels are required before undergoing advanced tests. Clinical chemistry tests thus form the center stage of the IVD market. The significant changes in this sector have been brought about as a result of the convergence of system engineering, automation, and IT technology. Thus, the new technologies have enabled a better understanding of disease processes.
The clinical chemistry market is expanding, consolidating, and becoming highly competitive with a myriad of opportunities for various new instruments, reagents, calibrators, and other systems. The largest segment of clinical chemistry is the general chemistry testing of the clinical chemistry market.
The introduction of user-friendly automated devices has minimized the human efforts and increased the efficiency of diagnostic procedures. For instance, the Ortho Clinical Vitros 350 Chemistry System accommodates up to 40 samples in one of its four trays, allowing laboratories to effectively meet the testing needs of the patient population. These systems, with their enhanced software and elaborate menu, are responsible for the speeding up of the treatment process at lower costs.
The key players of this market are Siemens, Abbott Laboratories, Danaher Corporation, Ortho Clinical Diagnostics, bioMerieux SA, Bio-rad, Alere, Becton Dickinson and Company, and Thermo Fisher Scientific.
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Clinical Chemistry The North American clinical chemistry market was estimated at $3,852.7 million in 2013 and is expected to reach $5,370.5 million by 2019, at a CAGR of 7.2% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report. |
Upcoming |
|
|
European Clinical Chemistry Although earlier, Europe showed a negative growth rate in the clinical chemistry market, in some countries revenues grew compared to 2011. Germany commanded the largest share (20%) at an estimated $652.8 million in 2013 and is expected to reach $853.3 million by 2018, at a CAGR of 5.8% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report. |
Upcoming |
|
|
Asia-Pacific Clinical Chemistry Analyzer The Asia-Pacific clinical chemistry market is growing in double digits and will continue to grow in future. China commanded the largest share (53%) at an estimated $516.81 million in 2013 and is expected to reach $1047.2 million by 2018, at a CAGR of 16.0% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report. |
Mar 2015 |
